BioSpace News Archive

€400,000 awarded to each of 12 recipients: The eleventh annual awards recognized the works of twelve researchers and their pivotal contributions in eight categories, from rising sea levels to the discovery of the microbiome

Iconic buildings partner with the National Safety Council to raise awareness of preventable deaths

EXUMA Biotechnology, a clinical-stage biotechnology company discovering and developing CAR-T products for solid tumors and affiliate of F1 Oncology, Inc., announced the expansion of its leadership team with the appointment of Wendy Li, M.D. as Chief Medical Officer and James Samuels as Chief Financial Officer.

Howard University Hospital Diabetes Treatment Center Encourages Residents to Get Tested

Correvio Pharma Corp. announced the results of voting at its 2019 Annual General Meeting of Shareholders held on June 18, 2019.

Kewaunee Scientific Corporation announced results for its fourth quarter and its fiscal year ended April 30, 2019.

Biohaven has granted the underwriters a 30-day option to purchase up to an additional 1,046,511 common shares at the public offering price, less underwriting discounts and commissions

Its work on life-changing treatments for serious diseases has earned Oxford Biomedica, a leading gene and cell therapy group, The Oxford Science Park Innovation Award 2019.